Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q908790> ?p ?o }
Showing triples 1 to 25 of
25
with 100 triples per page.
- Q908790 subject Q8621271.
- Q908790 abstract "Edotreotide (USAN, codenamed SMT487, also known as (DOTA0-Phe1-Tyr3)octreotide, or DOTATOC) is a substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain types of cancer.It has been the subject of a trial by the National Cancer Institute to determine its effects in young cancer patients (up to 25 years of age) for its ability to locate malignant cancer cells without harming normal cells. Specific cancers being included in the trial include neuroblastoma, childhood brain tumours and gastrointestinal cancer.".
- Q908790 iupacName "2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid".
- Q908790 thumbnail DOTATOC.png?width=300.
- Q908790 wikiPageWikiLink Q1483951.
- Q908790 wikiPageWikiLink Q161515.
- Q908790 wikiPageWikiLink Q170545.
- Q908790 wikiPageWikiLink Q188017.
- Q908790 wikiPageWikiLink Q192900.
- Q908790 wikiPageWikiLink Q233309.
- Q908790 wikiPageWikiLink Q4926095.
- Q908790 wikiPageWikiLink Q5205896.
- Q908790 wikiPageWikiLink Q5526839.
- Q908790 wikiPageWikiLink Q664846.
- Q908790 wikiPageWikiLink Q8621271.
- Q908790 wikiPageWikiLink Q938205.
- Q908790 iupacname "2".
- Q908790 type ChemicalCompound.
- Q908790 type ChemicalSubstance.
- Q908790 type ChemicalObject.
- Q908790 type Thing.
- Q908790 type Q11173.
- Q908790 comment "Edotreotide (USAN, codenamed SMT487, also known as (DOTA0-Phe1-Tyr3)octreotide, or DOTATOC) is a substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain types of cancer.It has been the subject of a trial by the National Cancer Institute to determine its effects in young cancer patients (up to 25 years of age) for its ability to locate malignant cancer cells without harming normal cells.".
- Q908790 label "Edotreotide".
- Q908790 depiction DOTATOC.png.